Viatris (VTRS) beats on Q1 earnings while sales surpass expectations. The company announces inaugural quarterly dividend.
Viatris Inc (NASDAQ: VTRS) reported Q1 net sales of $4.4 billion, down 6% Y/Y on a reported basis, but only down 2% compared to a combined loss of exclusivity. The sales beat the consensus of $4.1
PITTSBURGH, May 10, 2021 /PRNewswire/ -- Reports First Quarter 2021 Financial Results - Total Revenue of $4.4 billion, U.S. GAAP net loss of $1.0 billion, Adjusted EBITDA of $1.6 billion, U.S. GAAP ne

Is Generic-Drug Maker Viatris a Keeper?

03:31pm, Sunday, 09'th May 2021
It depends on what type of investor you are.
Investors will look forward to regular top and bottom-line numbers and updates on the merger synergies when Viatris (VTRS) reports Q1 results.

3 Low Price-Book Ratio Stock Picks

12:58pm, Friday, 30'th Apr 2021
Selecting stocks whose market capitalization surpasses $10 billion and whose price-book ratios are below 1.5 could provide value investors with a higher likelihood to find opportunities amid U.S.-list
PITTSBURGH, April 30, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Conferen
But that's not the best reason to consider buying it.

The Smartest Stocks to Buy With $100 Right Now

05:51am, Friday, 23'rd Apr 2021
These great companies can kick-start or further your journey toward financial freedom.

Bear of the Day: Viatris (VTRS)

08:16am, Thursday, 22'nd Apr 2021
Bear of the Day: Viatris (VTRS)

3 Best Value Stocks to Buy Now

06:25am, Wednesday, 14'th Apr 2021
On the hunt for bargains in today's overvalued market? Look no further.
Viatris's share price will continue to decrease in 2021, as their drug portfolio faces increasing generic competition. Historical EBITDA multiples show Viatris stock was traded in line with its peers

Better Value Stock: AbbVie or Viatris?

06:01am, Saturday, 10'th Apr 2021
Look at more than just the valuation metrics.

Which COVID Vaccine Stock Is the Best Pick?

06:05am, Wednesday, 24'th Mar 2021
This question has multiple right answers.
The stock of Viatris (NAS:VTRS, 30-year Financials) appears to be modestly undervalued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE